静脉经皮腔内血管成形术治疗多发性硬化伴CCSVI的随机对照试验
意大利6个多发性硬化中心开展的随机双盲假手术对照试验,纳入115例复发缓解型多发性硬化患者,按2:1分为静脉经皮腔内血管成形术组与假手术组,随访12个月。两组复合功能指标无差异,影像学新发病灶在6至12个月时名义上有差异但校正后无统计学意义,且未发生严重不良事件。
要点
- 静脉PTA未改善12个月复合功能指标,不能推荐用于多发性硬化患者。
- PTA组仅54%实现血流恢复,提示该技术操作成功率有限。
- 6至12个月新发病灶差异在校正后无统计学意义,需谨慎解读。
核心结论
- 静脉PTA是安全的,但疗效有限,该治疗不能推荐用于多发性硬化患者。
研究设计与样本
- 随机、双盲、假手术对照、平行组试验,在意大利6个多发性硬化中心开展,2012年8月开始、2016年3月结束。
- 共纳入115例复发缓解型多发性硬化患者,按2:1随机分入静脉PTA组(76例)与假手术组(39例),采用意向性分析。
主要发现
- 静脉PTA组38/71例(54%)实现血流恢复,未发生严重不良事件。
关键数值与推荐
- 复合功能指标包含步行控制、平衡、手部灵活性、排尿后残余尿量和视力。
- MRI合并病灶包括T1钆增强病灶以及新增或扩大的T2病灶。
临床怎么用
- 对于多发性硬化患者,不应将静脉PTA作为改善功能或影像学病灶的治疗手段。
- 对合并CCSVI的多发性硬化患者应继续以疾病修正治疗为核心,并告知静脉PTA缺乏获益证据。
局限性
- 47例(26.6%)筛查时无CCSVI而被排除,样本量较小且仅限复发缓解型患者。
- 主要影像学终点校正后未达统计学显著,6至12个月结果可能受多重比较影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Chronic cerebrospinal venous insufficiency (CCSVI) is characterized by restricted venous outflow from the brain and spinal cord. Whether this condition is associated with multiple sclerosis (MS) and whether venous percutaneous transluminal angioplasty (PTA) is beneficial in persons with MS and CCSVI is controversial. OBJECTIVE: To determine the efficacy and safety of venous PTA in patients with MS and CCSVI. DESIGN, SETTING, AND PARTICIPANTS: We analyzed 177 patients with relapsing-remitting MS; 62 were ineligible, including 47 (26.6%) who did not have CCSVI on color Doppler ultrasonography screening. A total of 115 patients were recruited in the study timeframe. All patients underwent a randomized, double-blind, sham-controlled, parallel-group trial in 6 MS centers in Italy. The trial began in August 2012 and concluded in March 2016; data were analyzed from April 2016 to September 2016. The analysis was intention to treat. INTERVENTIONS: Patients were randomly allocated (2:1) to either venous PTA or catheter venography without venous angioplasty (sham). MAIN OUTCOMES AND MEASURES: Two primary end points were assessed at 12 months: (1) a composite functional measure (ie, walking control, balance, manual dexterity, postvoid residual urine volume, and visual acuity) and (2) a measure of new combined brain lesions on magnetic resonance imaging, including the proportion of lesion-free patients. Combined lesions included T1 gadolinium-enhancing lesions plus new or enlarged T2 lesions. RESULTS: Of the included 115 patients with relapsing-remitting MS, 76 were allocated to the PTA group (45 female [59%]; mean [SD] age, 40.0 [10.3] years) and 39 to the sham group (29 female [74%]; mean [SD] age, 37.5 [10.6] years); 112 (97.4%) completed follow-up. No serious adverse events occurred. Flow restoration was achieved in 38 of 71 patients (54%) in the PTA group. The functional composite measure did not differ between the PTA and sham groups (41.7% vs 48.7%; odds ratio, 0.75; 95% CI, 0.34-1.68; P = .49). The mean (SD) number of combined lesions on magnetic resonance imaging at 6 to 12 months were 0.47 (1.19) in the PTA group vs 1.27 (2.65) in the sham group (mean ratio, 0.37; 95% CI, 0.15-0.91; P = .03: adjusted P = .09) and were 1.40 (4.21) in the PTA group vs 1.95 (3.73) in the sham group at 0 to 12 months (mean ratio, 0.72; 95% CI, 0.32-1.63; P = .45; adjusted P = .45). At follow-up after 6 to 12 months, 58 of 70 patients (83%) in the PTA group and 22 of 33 (67%) in the sham group were free of new lesions on magnetic resonance imaging (odds ratio, 2.64; 95% CI, 1.11-6.28; P = .03; adjusted P = .09). At 0 to 12 months, 46 of 73 patients (63.0%) in the PTA group and 18 of 37 (49%) in the sham group were free of new lesions on magnetic resonance imaging (odds ratio, 1.80; 95% CI, 0.81-4.01; P = .15; adjusted P = .30). CONCLUSION AND RELEVANCE: Venous PTA has proven to be a safe but largely ineffective technique; the treatment cannot be recommended in patients with MS. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01371760.
引用
- Zamboni P, Tesio L, Galimberti S, et al. Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial. JAMA Neurol. 2018. PMID: 29150995. doi:10.1001/jamaneurol.2017.3825
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。